These patents relate to the unique design of the company’s Endoskeleton line of interbody devices as well as various aspects of composite devices featuring a combination of metal and polymer materials, such as polyetheretherketone (PEEK).

Titan Spine now has over 40 patents in their portfolio and currently under review.

Titan Spine president Kevin Gemas noted the addition of these 13 patents in 2013 exemplifies the company’s continued commitment to protect and broaden its intellectual property in the interbody fusion space.

"Several of these new patents extend to composite interbody device designs even though they do not align with our philosophy of the superiority of an interbody device constructed entirely of titanium. We made the decision to include them as part of our comprehensive IP approach," Gemas added.

Titan Spine’s proprietary surface technology has been shown to promote a superior osteogenic environment when compared to smooth titanium or PEEK.

This surface technology, which contains unique topographies at the macro, micro, and sub-micron levels, is featured on the company’s line of Endoskeleton interbody devices for the cervical and lumbar spine.

An additional aspect of the Endoskeleton design that is covered by one of these new patents is the presence of transverse and anterior/posterior windows optimized for strength, visualization of bone graft integration and loading of bone graft for improved fusion.